Advertisement
Advertisement
BDSX
Biodesix, Inc. Common Stock
10.39
USDSponsored
+0.43
+4.37%
Feb 06, 15:59 UTC -5
Closed
After-Market
10.21
-0.19
-1.83%
BDSX Earnings Reports
Positive Surprise Ratio
BDSX beat 13 of 21 last estimates.
62%
Next Report
Date of Next Report
Mar 02, 2026
Estimate for Q4 25 (Revenue/ EPS)
$26.24M
/-$0.87
Implied change from Q3 25 (Revenue/ EPS)
+20.56%
/-24.35%
Implied change from Q4 24 (Revenue/ EPS)
+28.46%
/-27.50%
Biodesix, Inc. Common Stock earnings per share and revenue
On Nov 03, 2025, BDSX reported earnings of -1.15 USD per share (EPS) for Q3 25, beating the estimate of -1.46 USD, resulting in a 21.02% surprise. Revenue reached 21.77 million, compared to an expected 21.39 million, with a 1.75% difference. The market reacted with a +19.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.87 USD, with revenue projected to reach 26.24 million USD, implying an decrease of -24.35% EPS, and increase of 20.56% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
FAQ
What were Biodesix, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Biodesix, Inc. Common Stock reported EPS of -$1.15, beating estimates by 21.02%, and revenue of $21.77M, 1.75% above expectations.
How did the market react to Biodesix, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 19.87%, changed from $6.34 before the earnings release to $7.60 the day after.
When is Biodesix, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 02, 2026.
What are the forecasts for Biodesix, Inc. Common Stock's next earnings report?
Based on 7
analysts, Biodesix, Inc. Common Stock is expected to report EPS of -$0.87 and revenue of $26.24M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement